MH has participated in advisory boards and/or symposia for Novo Nordisk, Sanofi-Aventis, Novartis, Eli Lilly, Merck Sharp & Dohme, Boehringer Ingelheim, AstraZeneca and Inova and received honoraria
The limitations relative to Retatrutide are real, though
For both drugs, extracellular GT activity is an essential and limiting step in their activation into membrane permeable compounds (Dilda et al., 2008
If you were on 2.4 mg semaglutide and experiencing diminishing returns, you might find that 1.7 mg after a reset produces stronger appetite suppression than 2.4 mg did before
Thanks, Rose on March 5, 2020 at 2:42 pm Hi Ariana, Im glad I came across your article